Page last updated: 2024-10-28

hydroxychloroquine and Malaria, Vivax

hydroxychloroquine has been researched along with Malaria, Vivax in 11 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Malaria, Vivax: Malaria caused by PLASMODIUM VIVAX. This form of malaria is less severe than MALARIA, FALCIPARUM, but there is a higher probability for relapses to occur. Febrile paroxysms often occur every other day.

Research Excerpts

ExcerptRelevanceReference
"vivax malaria is associated with the use of antimalarial chemoprophylaxis."1.33Chemoprophylaxis and the epidemiological characteristics of re-emergent P. vivax malaria in the Republic of Korea. ( Kim, C; Kim, RK; Oh, DK; Park, K; Shin, DC; Suh, IL; Yong, TS, 2006)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19903 (27.27)18.7374
1990's1 (9.09)18.2507
2000's4 (36.36)29.6817
2010's3 (27.27)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shin, S1
Park, SH1
Park, J1
ALVING, AS1
Lee, KS1
Kim, TH1
Kim, ES1
Lim, HS1
Yeom, JS1
Jun, G1
Park, JW1
Lee, SW1
Lee, M1
Lee, DD1
Kim, C3
Kim, YJ1
Kim, JY1
Green, MD1
Klein, TA2
Kim, HC2
Nettey, H1
Ko, DH1
Kim, H1
Park, I2
Hahm, C1
Huh, J1
Hwang, YS1
Choi, HJ1
Yang, HJ1
Chung, WS1
Kim, YK2
Kim, HY1
Choi, JY1
Kim, JM1
RIZK, E1
BERBERIAN, DA1
DENNIS, EW1
Shin, DC1
Yong, TS1
Oh, DK1
Kim, RK1
Park, K1
Suh, IL1
RUHE, DS1
COOPER, WC1
Kim, JS1
Oh, JS1
Chang, EA1
Bae, SY1
Nam, DH1
Lee, CH1
Yang, JH1
Lee, CK1
Lee, WJ1
Lim, CS1
Yi, KJ1
Chung, MH1
Kim, HS1
Kim, CS1
Pai, SH1

Other Studies

11 other studies available for hydroxychloroquine and Malaria, Vivax

ArticleYear
Incidental Identification of Plasmodium vivax During Routine Complete Blood Count Analysis Using the UniCel DxH 800.
    Annals of laboratory medicine, 2018, Volume: 38, Issue:2

    Topics: Antimalarials; Blood Cell Count; Humans; Hydroxychloroquine; Image Processing, Computer-Assisted; Ma

2018
Study of pentaquine and isopentaquine, therapeutic agents effective in reducing relapse rate in vivax malaria.
    Abstracts. International Congress on Tropical Medicine and Malaria (4th : 1948 : Washington, D. C.), 1948, Volume: 56, Issue:4th Congr

    Topics: Aminoquinolines; Hydroxychloroquine; Hydroxyquinolines; Malaria; Malaria, Vivax; Recurrence

1948
Short report: chloroquine-resistant Plasmodium vivax in the Republic of Korea.
    The American journal of tropical medicine and hygiene, 2009, Volume: 80, Issue:2

    Topics: Adult; Aged; Animals; Antimalarials; Chloroquine; Drug Resistance; Female; Humans; Hydroxychloroquin

2009
Biological resistance of hydroxychloroquine for Plasmodium vivax malaria in the Republic of Korea.
    The American journal of tropical medicine and hygiene, 2009, Volume: 81, Issue:4

    Topics: Adult; Animals; Antimalarials; Chloroquine; Drug Resistance; Humans; Hydroxychloroquine; Korea; Mala

2009
A case of Plasmodium vivax with unusual enlarged gametocytes.
    International journal of laboratory hematology, 2011, Volume: 33, Issue:2

    Topics: Antimalarials; Germ Cells; Humans; Hydroxychloroquine; Malaria, Vivax; Male; Plasmodium vivax; RNA,

2011
Therapeutic efficacy of chloroquine in Plasmodium vivax and the pvmdr1 polymorphisms in the Republic of Korea under mass chemoprophylaxis.
    The American journal of tropical medicine and hygiene, 2011, Volume: 84, Issue:4

    Topics: Antimalarials; Chloroquine; Drug Resistance; Humans; Hydroxychloroquine; Malaria, Vivax; Multidrug R

2011
Mass suppression of hyperendemic vivax malaria with hydroxychloroquine.
    Le Journal medical libanais. The Lebanese medical journal, 1960, Volume: 13

    Topics: Chloroquine; Humans; Hydroxychloroquine; Malaria; Malaria, Vivax

1960
Chemoprophylaxis and the epidemiological characteristics of re-emergent P. vivax malaria in the Republic of Korea.
    Bulletin of the World Health Organization, 2006, Volume: 84, Issue:10

    Topics: Animals; Antimalarials; Chemoprevention; Clothing; Drug Resistance; Episode of Care; Humans; Hydroxy

2006
Studies in human malaria; the protective and therapeutic action of SN 6911 against St. Elizabeth strain vivax malaria.
    American journal of hygiene, 1949, Volume: 49, Issue:1

    Topics: Hydroxychloroquine; Malaria; Malaria, Vivax; Quinolines

1949
Alteration of platelet counts and lipid profiles after treatment of acute Plasmodium vivax.
    Acta tropica, 2008, Volume: 106, Issue:1

    Topics: Adolescent; Adult; Animals; Antimalarials; Female; Humans; Hydroxychloroquine; Lipids; Malaria, Viva

2008
A relapsed case of imported tertian malaria after a standard course of hydroxychloroquine and primaquine therapy.
    The Korean journal of parasitology, 1998, Volume: 36, Issue:2

    Topics: Adult; Animals; Antimalarials; Humans; Hydroxychloroquine; Malaria, Vivax; Male; Primaquine; Recurre

1998